These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3229188)

  • 1. [A study on the immune function of erythrocyte in patients with leukemia].
    Cao D; Huang ZG; Cao WX
    Zhonghua Nei Ke Za Zhi; 1988 Oct; 27(10):634-7, 654. PubMed ID: 3229188
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression of A, B, and H antigens on erythrocytes of patients with leukemia].
    Ivanov EP; Levin VI; Smirnova LA; Molochko VA
    Gematol Transfuziol; 1990 Dec; 35(12):23-4. PubMed ID: 2083829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
    Ringdén O; Horowitz MM
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2989-92. PubMed ID: 2650409
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of the CDR3 structure of the Vβ21 T cell clone in patients with P210(BCR-ABL)-positive chronic myeloid leukemia and B-cell acute lymphoblastic leukemia.
    Zha X; Chen S; Yang L; Li B; Chen Y; Yan X; Li Y
    Hum Immunol; 2011 Oct; 72(10):798-804. PubMed ID: 21820025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunological indices of patients with chronic myeloleukemia at the blast crisis stage].
    Romanova AF; Fedorovskaia EA; Pesotskaia LA
    Vrach Delo; 1991 Apr; (4):65-7. PubMed ID: 2063572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
    Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
    Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating immune complexes in acute leukemia.
    Cermák J; Feyereislová A; Horejsí J
    Neoplasma; 1989; 36(1):21-7. PubMed ID: 2704422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience.
    Delia M; Pastore D; Mestice A; Carluccio P; Perrone T; Gaudio F; Ricco A; Sgherza N; Albano F; Specchia G
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):495-9. PubMed ID: 23200706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in treatment strategies for adult acute lymphoblastic leukemia (ALL) according to prognostic factors and minimal residual disease.
    Hoelzer D
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():66-70. PubMed ID: 2390642
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
    Alimoghaddam K; Ghaffari H; Foroughi F; Chardouli B; Sanaat Z; Bahar B; Mousavi A; Iravani M; Ghavamzadeh A
    Arch Iran Med; 2006 Apr; 9(2):99-103. PubMed ID: 16649348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients.
    Takahashi H; Furukawa T; Yano T; Sato N; Takizawa J; Kurasaki T; Abe T; Narita M; Masuko M; Koyama S; Toba K; Takahashi M; Aizawa Y
    Exp Hematol; 2007 Jul; 35(7):1091-9. PubMed ID: 17588478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular deformability studies in leukemia.
    Sharma K
    Physiol Chem Phys Med NMR; 1993; 25(4):293-7. PubMed ID: 8153154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipients of HLA-identical sibling marrow transplants with severe aplastic anemia engraft more quickly, and those with chronic myeloid leukemia more slowly, than those with acute leukemia.
    Atkinson K; Downs K; Ashby M; Dodds A; Concannon A; Biggs J
    Bone Marrow Transplant; 1989 Jan; 4(1):23-7. PubMed ID: 2647183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete phenotypic and genotypic lineage switch in a Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Pane F; Frigeri F; Camera A; Sindona M; Brighel F; Martinelli V; Luciano L; Selleri C; Del Vecchio L; Rotoli B; Salvatore F
    Leukemia; 1996 Apr; 10(4):741-5. PubMed ID: 8618457
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.
    Volpe G; Cignetti A; Panuzzo C; Kuka M; Vitaggio K; Brancaccio M; Perrone G; Rinaldi M; Prato G; Fava M; Geuna M; Pautasso M; Casnici C; Signori E; Tonon G; Tarone G; Marelli O; Fazio VM; Saglio G
    Cancer Res; 2007 Jun; 67(11):5300-7. PubMed ID: 17545610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
    Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
    Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.